Nav: Home

Cancer research symposium features internationally recognized experts

November 02, 2016

MINNEAPOLIS (Nov. 2, 2016) - The Masonic Cancer Center, University of Minnesota is hosting its 7th Annual Cancer Research Symposium today and tomorrow, Nov. 2-3, at TCF Bank Stadium. With the goal of celebrating 25 years of research innovation, discovery, and collaborations, the 2-day event will feature internationally recognized cancer researchers and doctors, many of who currently work or have trained at the Masonic Cancer Center, as well as current trainee presenters that represent the vision of tomorrow.

Together, these researchers and trainees will share the work they've explored in many areas of cancer research that have changed lives and move us in new directions.

"We're extremely excited to welcome back such esteemed cancer research experts to Minneapolis," said Dr. Douglas Yee, M.D., director of the Masonic Cancer Center. "Their trainee experience here at the Masonic Cancer Center--and the profound research they have led across the country--is invaluable and has made the fight to end cancer more attainable. We hope this motivational event will spur new ideas and collaborations toward developing new research."

Dr. Yee will deliver the opening remarks on Nov. 2, followed by a keynote address by one of the National Cancer Institute's Outstanding Investigators, Thomas Kensler, Ph.D., professor of Pharmacology and Chemical Biology at University of Pittsburgh's School of Medicine and Johns Hopkins Bloomberg School of Public Health.

Focal points of the symposium include presentations given by Masonic Cancer Center alumni who now work as investigators all over the United States. Topics that will be covered include everything from exercise rehabilitation after breast cancer, to the science of surviving cancer--lessons learned from cancer survivors, to taking apart the complex interactions that influence the evolution of cancer genomes.

Collaborations will be highlighted through engaging presentations, as well as on-site poster sessions that feature graduate students and postdoctoral research trainees sharing their most current cancer research findings.

"The Masonic Cancer Center, University of Minnesota is proud to bring together a scientifically diverse group of cancer researchers in an environment where they can foster new collaborations and generate new, innovative, and novel ideas," said Dr. Yee. "This event will also allow our graduate students and postdoctoral research trainees an opportunity to see what researchers around the United States are working on, and the types of studies and clinical trials they build on as they work to advance their own research careers."
-end-
For more information on the 7th Annual Cancer Research Symposium, including a complete list of sponsors and speakers, please visit the symposium event page.

Masonic Cancer Center, University of Minnesota is a Comprehensive Cancer Center designated by the National Cancer Institute. For more than 25 years, researchers, educators, and care providers have worked to discover the causes, prevention, detection, and treatment of cancer and cancer-related disease. Learn more about the Masonic Cancer Center at cancer.umn.edu.

University of Minnesota - Masonic Cancer Center

Related Breast Cancer Articles:

Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
Blood test offers improved breast cancer detection tool to reduce use of breast biopsy
A Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results and potentially reduce biopsies up to 67 percent.
Surgery to remove unaffected breast in early breast cancer increases
The proportion of women in the United States undergoing surgery for early-stage breast cancer who have preventive mastectomy to remove the unaffected breast increased significantly in recent years, particularly among younger women, and varied substantially across states.
Breast cancer patients with dense breast tissue more likely to develop contralateral disease
Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the contralateral breast, according to new research from The University of Texas MD Anderson Cancer.
Some early breast cancer patients benefit more from breast conservation than from mastectomy
Breast conserving therapy (BCT) is better than mastectomy for patients with some types of early breast cancer, according to results from the largest study to date, presented at ECC2017.
One-third of breast cancer patients not getting appropriate breast imaging follow-up exam
An annual mammogram is recommended after treatment for breast cancer, but nearly one-third of women diagnosed with breast cancer aren't receiving this follow-up exam, according to new findings presented at the 2016 Annual Clinical Congress of the American College of Surgeons.
Low breast density worsens prognosis in breast cancer
Even though dense breast tissue is a risk factor for breast cancer, very low mammographic breast density is associated with a worse prognosis in breast cancer patients.
Is breast conserving therapy or mastectomy better for early breast cancer?
Young women with early breast cancer face a difficult choice about whether to opt for a mastectomy or breast conserving therapy (BCT).
Breast density and outcomes of supplemental breast cancer screening
In a study appearing in the April 26 issue of JAMA, Elizabeth A.
Full dose radiotherapy to whole breast may not be needed in early breast cancer
Five years after breast-conserving surgery, radiotherapy focused around the tumor bed is as good at preventing recurrence as irradiating the whole breast, with fewer side effects, researchers from the UK have found in the large IMPORT LOW trial.

Related Breast Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".